Effect of AZD4017, a Selective 11β-HSD1 Inhibitor, on Bone Turnover Markers in Postmenopausal OsteopeniaAfroze Abbas, Paul M. Stewart, Marian Schini et al.|The Journal of Clinical Endocrinology & Metabolism|2022Cited by 11
Denosumab in clinical practice: efficacy, complications and adherenceRebecca Sagar, Afroze Abbas, S.B. Potts et al.|Endocrine Abstracts|2019Cited by 0